CA2304461A1 - Complexes metalliques lipophiles pour imagerie de necrose ou d'infarcissement - Google Patents

Complexes metalliques lipophiles pour imagerie de necrose ou d'infarcissement Download PDF

Info

Publication number
CA2304461A1
CA2304461A1 CA002304461A CA2304461A CA2304461A1 CA 2304461 A1 CA2304461 A1 CA 2304461A1 CA 002304461 A CA002304461 A CA 002304461A CA 2304461 A CA2304461 A CA 2304461A CA 2304461 A1 CA2304461 A1 CA 2304461A1
Authority
CA
Canada
Prior art keywords
necrosis
metal complexes
lipophilic metal
imaging
infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002304461A
Other languages
English (en)
Other versions
CA2304461C (fr
Inventor
Johannes Platzek
Ulrich Speck
Ulrich Niedballa
Bernd Raduchel
Hanns-Joachim Weinmann
Wolfgang Ebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2304461A1 publication Critical patent/CA2304461A1/fr
Application granted granted Critical
Publication of CA2304461C publication Critical patent/CA2304461C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002304461A 1997-09-26 1998-08-17 Complexes metalliques lipophiles pour imagerie de necrose ou d'infarcissement Expired - Fee Related CA2304461C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19744004.5 1997-09-26
DE1997144004 DE19744004C1 (de) 1997-09-26 1997-09-26 Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
PCT/EP1998/005185 WO1999016474A1 (fr) 1997-09-26 1998-08-17 Complexes metalliques lipophiles pour necroses et imagerie de l'infarctus

Publications (2)

Publication Number Publication Date
CA2304461A1 true CA2304461A1 (fr) 1999-04-08
CA2304461C CA2304461C (fr) 2008-10-14

Family

ID=7844677

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002304461A Expired - Fee Related CA2304461C (fr) 1997-09-26 1998-08-17 Complexes metalliques lipophiles pour imagerie de necrose ou d'infarcissement

Country Status (7)

Country Link
EP (1) EP1017424A1 (fr)
JP (1) JP2001518454A (fr)
AU (1) AU9262898A (fr)
CA (1) CA2304461C (fr)
DE (1) DE19744004C1 (fr)
NO (1) NO321235B1 (fr)
WO (1) WO1999016474A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146126A0 (en) 1999-04-30 2002-07-25 Slil Biomedical Corp Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
US7312244B2 (en) 1999-04-30 2007-12-25 Cellgate, Inc. Polyamine analog-amino acid conjugates useful as anticancer agents
TW462515U (en) * 1999-08-04 2001-11-01 Chiang Li Network perfume device
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
DE102005033903B4 (de) * 2005-07-15 2007-08-09 Bayer Schering Pharma Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033902B3 (de) * 2005-07-15 2007-04-05 Schering Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
IT1224416B (it) * 1987-12-24 1990-10-04 Bracco Ind Chimica Spa Chelanti macrociclici e loro chelati
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
DE3922005A1 (de) * 1989-06-30 1991-01-10 Schering Ag Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
WO1994001393A1 (fr) * 1992-07-03 1994-01-20 The Green Cross Corporation Nouveau chelateur, complexe compose dudit chelateur et d'un atome metallique, et agent diagnostique renfermant ledit complexe
US5358704A (en) * 1993-09-30 1994-10-25 Bristol-Myers Squibb Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
EP0758907A1 (fr) * 1994-05-11 1997-02-26 Schering Aktiengesellschaft Utilisation de composes a base d'un complexe de porphyrine ou d'un complexe de porphyrine etendue comme preparation diagnostique pour la localisation d'un infarctus
TW319763B (fr) * 1995-02-01 1997-11-11 Epix Medical Inc
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
WO1997030734A1 (fr) * 1996-02-21 1997-08-28 Mallinckrodt Medical, Inc. Agents utilises en resonance magnetique sur le pool sanguin
AU4753997A (en) * 1996-10-16 1998-05-11 Burnham Institute, The Magnetic resonance imaging of thrombi

Also Published As

Publication number Publication date
DE19744004C1 (de) 1999-07-22
JP2001518454A (ja) 2001-10-16
NO321235B1 (no) 2006-04-10
NO20001520L (no) 2000-05-25
CA2304461C (fr) 2008-10-14
AU9262898A (en) 1999-04-23
NO20001520D0 (no) 2000-03-23
EP1017424A1 (fr) 2000-07-12
WO1999016474A1 (fr) 1999-04-08

Similar Documents

Publication Publication Date Title
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
CA2225813A1 (fr) Marcfortines et paraherquamides antiparasitaires
CA2268321A1 (fr) Utilisation de complexes metalliques pour traiter les infections gastro-intestinales
AU9342898A (en) Contrasting agent for infarct and necrosis imaging
CA2137522A1 (fr) Alliages austenitiques et utilisation
WO1997030082A3 (fr) Peptide antibacterien et antifongique
CA2304461A1 (fr) Complexes metalliques lipophiles pour imagerie de necrose ou d'infarcissement
WO2000052194A3 (fr) Procede pour detecter une activite de caspase due a une membrane et modulateurs conçus a cet effet
AU3713695A (en) Locking device, e.g., for weapons or the like
CA2149969A1 (fr) Compositions pour concentre en suspension d'agents insecticides et acaricides a base d'arylpyrrole
WO2000057187A3 (fr) Methodes et reactifs destines au diagnostic et au traitement de la sclerose en plaques
RU96104383A (ru) Высокопрочный сплав припоя
AU4088097A (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta(b)benzofurans
WO2002072790A3 (fr) Interaction tsg101-gag et son utilisation
IL111817A0 (en) Halogen-containing metal complexes, diagnostic agents containing the same and processes for the preparation thereof
CA2304130A1 (fr) Nouveau derive du ligand fas
AU1179601A (en) An arrangement for h.323 proxies
RU97100759A (ru) Мазь для лечения ожогов
AU2158799A (en) Polyrotaxanes
RU96118858A (ru) Дисперсно-упрочненный материал для электродов контактной сварки
AU3151999A (en) Peptide ligand having specific affinity for the hiv1 retrovirus p24 protein
RU97104858A (ru) Дисперсно-упрочненный материал для электродов сварочных машин
WO1999065450A3 (fr) Agents immunosuppresseurs inhibant la fonction calcineurine et utilisations de ceux-ci
EP1083224A3 (fr) Protéine liant l' apoptine
RU97108789A (ru) Высокопрочный чугун

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed